text: <unk>  is an Antineoplastic agent and platinum coordination complex that is FDA approved for the treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor, advanced colorectal cancer. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include peripheral sensory neuropathy, neutropenia, thrombocytopenia, anemia, nausea, increase in transaminases and alkaline phosphatase, diarrhea, emesis, fatigue and stomatitis.
option_0: Oxaliplatin
option_1: Capecitabine
option_2: Satraplatin
option_3: Carboplatin
option_4: Ifosfamide
option_5: Zorubicin
option_6: Etoposide 
option_7: Cisplatin